Client News

Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC

NVision Advances Its Quantum Platform With Expansion Into South Korea

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

Novogenia AG Invests in State-of-the-Art Healthcare and Manufacturing Technologies at Its New Hallwang Headquarters

Darwin AG becomes Novogenia AG, strengthening its international position

Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars

Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment

Abivax Announces Closing of $920 Million Public Offering

AFYREN announces the resumption of production at its plant after the successful technical shutdown

REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION